El-Sabrout R - Search Results

1

Rapamycin reduces rejection in heart transplant recipients.

Radovancevic B, El-Sabrout R, Thomas C, Radovancevic R, Frazier OH, Van Buren C. Radovancevic B, et al. Transplant Proc. 2001 Nov-Dec;33(7-8):3221-2. doi: 10.1016/s0041-1345(01)02370-3. Transplant Proc. 2001. PMID: 11750381 Clinical Trial. No abstract available.

2

Guillain-Barré syndrome after solid organ transplantation.

El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren CT. El-Sabrout RA, et al. Transplantation. 2001 May 15;71(9):1311-6. doi: 10.1097/00007890-200105150-00023. Transplantation. 2001. PMID: 11397969 Review.

3

Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching.

Gruber SA, Katz S, Kaplan B, Clark JH 3rd, Chen PC, El-Sabrout R, Kerman RH. Gruber SA, et al. Transplantation. 2000 Jul 27;70(2):388-91. doi: 10.1097/00007890-200007270-00028. Transplantation. 2000. PMID: 10933170

4

Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.

El-Sabrout R, Weiss R, Butt F, Delaney V, Qadir M, Hanson P, Butt K. El-Sabrout R, et al. Transplant Proc. 2002 Aug;34(5):1942-3. doi: 10.1016/s0041-1345(02)03130-5. Transplant Proc. 2002. PMID: 12176636 Clinical Trial. No abstract available.

5

Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.

Rashid I, El-Sabrout R, Butt F, Delaney V, Qadir M, Hanson P, Butt K. Rashid I, et al. Transplant Proc. 2002 Aug;34(5):1649-50. doi: 10.1016/s0041-1345(02)02965-2. Transplant Proc. 2002. PMID: 12176520 No abstract available.

6

Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination.

El-Sabrout R, Weiss R, Butt F, Rashid I, Delaney V, Qadir M, Hanson P, Butt K. El-Sabrout R, et al. Transplant Proc. 2002 Aug;34(5):1946-7. doi: 10.1016/s0041-1345(02)03132-9. Transplant Proc. 2002. PMID: 12176638 Clinical Trial. No abstract available.

7

Improved freedom from rejection after a loading dose of sirolimus.

El-Sabrout R, Delaney V, Butt F, Qadir M, Hanson P, Tuteja S, McCollum DA, Butt K. El-Sabrout R, et al. Transplantation. 2003 Jan 15;75(1):86-90. doi: 10.1097/00007890-200301150-00016. Transplantation. 2003. PMID: 12544877

8

Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants.

El-Sabrout R, Delaney V, Butt F, Qadir M, Rashid I, Hanson P, Butt K. El-Sabrout R, et al. Transplant Proc. 2002 Aug;34(5):1627-8. doi: 10.1016/s0041-1345(02)02957-3. Transplant Proc. 2002. PMID: 12176512 No abstract available.

9

Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience.

El-Sabrout R, Delaney V, Qadir M, Butt F, Hanson P, Butt KM. El-Sabrout R, et al. Transplant Proc. 2003 May;35(3 Suppl):89S-94S. doi: 10.1016/s0041-1345(03)00220-3. Transplant Proc. 2003. PMID: 12742474 No abstract available.

10

Etiology and pathogenesis of posttransplant tumors: new insights into viral oncogenesis.

el-Sabrout R, Gruber SA. el-Sabrout R, et al. Ann Transplant. 1997;2(4):67-9. Ann Transplant. 1997. PMID: 9869881 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters